Did you know in 2023, biologics accounted for more than half of the $435 billion spent on drugs in the United States? Check out the newest information on how biosimilars are impacting prescription drug spend on the cost of benefits.
Biosimilars offer the same therapeutic benefits as biologics but at a much lower cost, and more are expected to enter the market each year. Employers should be taking certain steps now to take advantage of these (oftentimes substantial!) savings. ?? Have your HR or benefits teams talked with your PBM about biosimilar drugs, yet? Here's what to know: https://bit.ly/4igPPmG #AlliantInsurance #employeebenefits #humanresources #hr #cfo #pharmacy #biosimilars